{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Intraoperative Molecular Imaging with a Targeted Contrast Agent for Lung Adenocarcinomas"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial enrolled 50 patients"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility required confirmed adenocarcinoma diagnosis."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients received 0.1 mg/kg of a fluorescent folate receptor alpha (FR\u03b1)-targeted molecular contrast agent intravenously pre-surgery."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial assesses a targeted molecular contrast agent for real-time optical imaging of lung adenocarcinomas during surgery."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was intraoperative identification of fluorescent tumors."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This randomised controlled trial enrolled 50 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Analysis was per-protocol."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Of 50 patients, 46 (92%) exhibited fluorescent tumors."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: [Trial registration number]."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: [Source of funding]."
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}